YA II PN, Ltd. - 31 Dec 2025 SCHEDULE 13G/A Report for Indaptus Therapeutics, Inc. Common Stock (INDP)

Filing Manager
YA II PN, Ltd.
Reporting Manager
YA II PN, Ltd.
Security
Indaptus Therapeutics, Inc. Common Stock
Symbol
INDP
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
06 Apr 2026, 16:40:14 UTC
Date of event
31 Dec 2025
Previous filing
18 Feb 2025
SEC
View on sec.gov

Quoteable Key Fact

"YA II PN, Ltd. disclosed 0% ownership in Indaptus Therapeutics, Inc. Common Stock (INDP) on 31 Dec 2025."

Quick Takeaways

  • YA II PN, Ltd. filed SCHEDULE 13G/A for Indaptus Therapeutics, Inc. Common Stock (INDP).
  • Disclosed ownership: 0%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 18 Feb 2025.
  • Current filing was accepted on 06 Apr 2026, 16:40.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
YA II PN, Ltd. 0% 0 0 0 /s/ David Gonzalez David Gonzalez, General Counsel
YA Global Investments II (U.S.), LP 0% 0 0 0 /s/ David Gonzalez David Gonzalez, General Counsel
Yorkville Advisors Global, LP 0% 0 0 0 /s/ David Gonzalez David Gonzalez, General Counsel
Yorkville Advisors Global II, LLC 0% 0 0 0 /s/ David Gonzalez David Gonzalez, General Counsel
YAII GP, LP 0% 0 0 0 /s/ David Gonzalez David Gonzalez, General Counsel
YAII GP II, LLC 0% 0 0 0 /s/ David Gonzalez David Gonzalez, General Counsel
Mark Angelo 0% 0 0 0 /s/ Mark Angelo Mark Angelo
SC-Sigma Global Partners, LP 0% 0 0 0 /s/ David Gonzalez David Gonzalez, General Counsel